Table 2 NPS cases characteristics
NPS self-reported | Age/ gender | NPS dose self-reported | Co-ingestion alcohol | Clinical presentation | Treatment | Tox. laboratory analysis | Outcome |
|---|---|---|---|---|---|---|---|
Methylone | 32/ female | 1 - 1.5 g cumulative during 6.5 h | yes | Palpitations, fear, agitation, sweating, tremor, vertigo, paraesthesias, muscle twitching, vomiting | 1 mg sublingual lorazepam 10 mg i.v. metoclopramide intravenous fluid administration | Negative (immunoassay) | Discharged home the same day |
2C-B | 19/ male | 25 mg | yes | Severe hallucinations, mydriasis, tachycardia, agitation, confusion | benzodiazepines 4 mg i.v. haloperidol | 2C-P (liquid chromatography-mass spectrometry) | Discharged home 11 h later |